UBS AM’s Arcturus Therapeutics ARCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $503K | Sell |
|
|||||
|
2024
Q4 | $886K | Sell |
|
|||||
|
2024
Q3 | $4.78M | Buy |
|
|||||
|
2024
Q2 | $5.01M | Buy |
|
|||||
|
2024
Q1 | $6.09M | Buy |
|
|||||
|
2023
Q4 | $818K | Buy |
|
|||||
|
2023
Q3 | $594K | Buy |
|
|||||
|
2023
Q2 | $405K | Hold |
|
|||||
|
2023
Q1 | $405K | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $477K | Hold |
|
|||||
|
2021
Q4 | $655K | Sell |
|
|||||
|
2021
Q3 | $905K | Buy |
|
|||||
|
2021
Q2 | $632K | Buy |
|
|||||
|
2021
Q1 | $670K | Buy |
|
|||||
|
2020
Q4 | $633K | Buy |
|
|||||
|
2020
Q3 | $613K | Buy |
|
|||||
|
2020
Q2 | $519K | Buy |
|